Mechanisms of cytotoxicity of selected organogold(III) compounds

J Med Chem. 2005 Oct 20;48(21):6761-5. doi: 10.1021/jm050493o.

Abstract

The effects of a few cytotoxic organogold(III) compounds on ovarian A2780 human cancer cells were investigated in comparison to cisplatin and oxaliplatin. The tested compounds produced significant antiproliferative effects and promoted apoptosis to a greater extent than platinum drugs while causing only modest cell cycle modifications. The mechanistic implications of these findings are discussed: mitochondrial pathways are proposed to be directly involved in the apoptotic process in relation to selective inhibition of thioredoxin reductase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Humans
  • Organogold Compounds / chemistry
  • Organogold Compounds / pharmacology*
  • Structure-Activity Relationship

Substances

  • (6-(1,1-dimethylbenzyl)-2,2'-bipyridine)(2,6-xylidine)gold(III)
  • Antineoplastic Agents
  • Organogold Compounds
  • diacetato(2-(1,1-dimethylbenzyl)pyridine)gold(III)